Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Optical 76
Immune Disorders Drugs 74
Optical Disorders Drugs 66
Cardiovascular Drugs 42
Musculoskeletal Disorders Drugs 38
Dermatological Drugs 37
Drug Discovery 36
Biopharmaceuticals 36
Biotechnology 33
Genomics 27
Clinical Trials 19
Endocrine and Metabolic Disorders Drugs 19
Allergy and Immunology 18
Central Nervous System Drugs 18
Pharmaceuticals 18
Skin Cancer Drugs 18
Infectious Diseases Drugs 16
Drugs by Therapeutic Area 14
Respiratory Drugs 14
Infusions and Injectables 13
Allergy Drugs 13
Lung Cancer Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Diagnostics 7
Needles and Syringes 7
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Prostate Cancer Drugs 5
Drug Delivery 5
Gastroenterology 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Immunosuppressive Drugs 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Lymphoma Drugs 3
Colon Cancer Drugs 3
Brain Cancer Drugs 3
Cardiovascular Devices 3
Analgesics 3
Medical Devices 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Neurology 2
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Cardiology 2
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Palliative Care 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

652 Results (Page 28 of 33)
- Relevance
  Sort by

TNF Alpha Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

$Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€3972EUR$4,500USD£3,424GBP

Placenta Growth Factor Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1324EUR$1,500USD£1,141GBP

Gene Editing Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antisense & RNAi Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

DNA Repair Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

Blood Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

Myasthenia Gravis- Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1765EUR$2,000USD£1,522GBP

Bi-Specific MAbS Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3963EUR$4,490USD£3,416GBP

Myostatin Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1103EUR$1,250USD£951GBP

Fibrodysplasia Ossificans Progressive - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1103EUR$1,250USD£951GBP

CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

 Report
August 2022
121 Pages
Global

From

€1147EUR$1,299USD£988GBP

Retinal Vein Occlusion Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€3972EUR$4,500USD£3,424GBP

Skeletal Dysplasia Market

 Report
January 2024
200 Pages
Global

From

€3663EUR$4,150USD£3,158GBP

CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

 Report
April 2022
116 Pages
Global

From

€1147EUR$1,299USD£988GBP

Fibrodysplasia Ossificans Progressiva Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,248USD£3,123GBP

Global Genome Editing/Genome Engineering Market by Application, Technology, and End User, Regional Outlook - Forecast up to 2030

 Report
January 2024
130 Pages
Global

From

€3972EUR$4,500USD£3,424GBP

Graves Ophthalmopathy - Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
161 Pages
Global

From

€6620EUR$7,500USD£5,707GBP

Retinal Vein Occlusion Treatment Market Size, Share & Trends Analysis Report By End-user (Retail Pharmacy, Hospital & Clinics), By Disease Type (CRVO, BRVO), By Treatment (Anti-VEGF, Corticosteroid Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
180 Pages
Global

From

€5252EUR$5,950USD£4,527GBP

652 Results (Page 28 of 33)
- 1
- 26
- 27
- 28
- 29
- 30

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.